Outcome of Hearings on CRISPR Patents Tough to Predict

Überblick


Robert Underwood called it a “dicey exercise” to try to predict the outcome of a hearing at the US Patent and Trademark Office regarding two patents for clustered, regularly interspaced short palindromic repeats (CRISPR), a pivotal new life sciences genetic technology.